Jeffery J. Bednarski, MD, PhD

  • Division Director, Pediatric Hematology, Oncology and Stem Cell Transplantation
  • Associate Professor of Pediatrics

Dr. Jeff Bednarski, MD, PhD is a Pediatric Hematologist/Oncologist at UPMC Children’s Hospital of Pittsburgh and Division Director of Pediatric Hematology, Oncology, and Stem Cell Transplantation. He specializes in the treatment of children with blood disorders and immune deficiencies. Dr. Bednarski conducts research on the early stages of immune system development and how errors in normal developmental programs lead to immune disorders or leukemia in children. His research has been funded by American Society of Hematology, Hyundai Hope on Wheels, and National Institutes of Health. Dr. Bednarski’s goal is to better understand how cancer and immune deficiencies develop in order to design improved therapies. He has led clinical trials to improve bone marrow transplant for patients with immune deficiency and to bring new immune therapies to treatment of children with leukemia. Dr. Bednarski attended medical school at the University of Michigan, completed his residency in pediatrics at St. Louis Children’s Hospital and his fellowship in hematology/oncology at Washington University School of Medicine.

Professional and Scientific Society Memberships

  • American Academy of Pediatrics, 2003 – present
  • American Society of Hematology, 2012 – present
  • Primary Immune Deficiency Treatment Consortium, 2017 – present 
  • North American Pediatric Aplastic Anemia Consortium, 2020 – 2024
  • Clinical Immunology Society, 2020 – present
  • American Society for Transplantation and Cellular Therapy, 2020 – present
  • Society of Pediatric Research, 2020 – present
  • American Association of Immunologists, 2022 - present

Education & Training

  • BS, Duke University, 1995
  • MD, University of Michigan, 2003
  • PhD, University of Michigan, 2003

Selected Publications

Academic and Research Interests

  • Immune Cell Development
  • DNA Damage responses
  • Inborn errors of immunity
  • Stem cell transplant and cellular therapy
  • Pediatric cancer